Charnita M. Zeigler-Johnson, PhD
|CCEB Appointment||Adjunct Scholar, Epidemiology|
|Non-Penn Appointment||Assistant Professor, Department of Medical Oncology|
Dr. Zeigler-Johnson's research focuses on the molecular epidemiology of prostate cancer.
H Rennert, CM Zeigler-Johnson, K Addya, MJ Finley, AH Walker, E Spangler, DGB Leonard, A Wein, SB Malkowicz, TR Rebbeck. Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. (2005) Cancer Epidemiology, Biomarkers and Prevention, 14 (4):949-957.
E Spangler, CM Zeigler-Johnson, A Wein, SB Malkowicz, TR Rebbeck. Association of prostate cancer family history with clinical and tumor characteristics of prostate tumors. (2005) International Journal of Cancer, 113:471-474.
C Zeigler-Johnson, T Friebel, A Walker, Y Wang, E Spangler, S Panossian, M Patacsil, R Aplenc, AJ Wein, SB Malkowicz, TR Rebbeck (2004). CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer. Cancer Research, 64(22):8461-8467.
C Zeigler-Johnson, S Panossian, SM Gueye, M Jalloh, D Ofori-Adjei, PA Kanetsky. (2004) Ethnic differences in the frequency of the agouti signaling protein G.8818A>G polymorphism. Pigment Cell Res. 17:185-187.
SM Gueye, CM Zeigler-Johnson, T Friebel, E Spangler, M Jalloh, S MacBride, SB Malkowicz, TR Rebbeck. Clinical characteristics of prostate cancer in African Americans, American Whites, and Senegalese Men. Urology, 2003, 61:987-992.
CM Zeigler-Johnson, AH Walker, B Mancke, E Spangler, M Jalloh, S McBride, A Deitz, SB Malkowicz , D Ofori-Adjei, SM Gueye, TR Rebbeck. Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4. Human Heredity, 2002, 54:13-21.C Zeigler-Johnson. CYP3A4: A potential prostate cancer risk factor for high-risk groups. Clinical Journal of Oncology Nursing 2001, 5(4): 153-154.
TR Rebbeck, AH Walker, C Zeigler-Johnson, S Weisburg, A-M Martin, KL Nathanson, AJ Wein, SB Malkowicz. Association of HPC2/ELAC2 genotypes and prostate cancer. American Journal of Human Genetics 2000, 67:1014-1019.